Medicine in Europe

Medicine in Europe

Important principles of the drug policy are currently regulated on a European level. This is of double significance. Firstly, the population in Europe is directly affected. But European policy regarding drug regulation has also indirect effects on the population in poor regions of the Third World . In collaboration with partner organisations of Health Action International BUKO Pharma-Kampagne establishes a counterweight to the massive lobby the pharmaceutical industry has in Brussels.

BUKO Pharma-Kampagne actively follows the processes of the drug legislation both on national and European level. Important aims are:

· Transparency of prescription drug approval
· Strengthening of pharmacovigilance
· Independent information on drugs
· Control of dishonest advertisement for drugs
· Research policy in the sense of drugs as public good

Top